Amanote Research
Register
Sign In
Targeted Treatment of Recurrent Platinum-Resistant Ovarian Cancer: Current and Emerging Therapies
Cancer Management and Research
- New Zealand
doi 10.2147/cmr.s8759
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
December 1, 2010
Authors
Anda Vlad
Publisher
Dove Medical Press Ltd.
Related search
Ovarian Cancer: Emerging Molecular-Targeted Therapies
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Oral Melphalan as a Treatment for Platinum-Resistant Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology
Metastatic Triple Negative Breast Cancer: Optimizing Treatment Options, New and Emerging Targeted Therapies
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Emerging Treatment Options for Recurrent Ovarian Cancer: The Potential Role of Olaparib
OncoTargets and Therapy
Oncology
Pharmacology
The Use of Treosulfan and Gemcitabine in the Treatment of Platinum-Resistant Ovarian Cancer
Oncology Letters
Cancer Research
Oncology
Emerging Role for Bevacizumab in Combination With Chemotherapy for Patients With Platinum-Resistant Ovarian Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Prm212 - Patient Experience With Platinum-Resistant or Platinum-Refractory Ovarian Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Chemotherapy-Free Strategy for Platinum-Sensitive Recurrent Ovarian Cancer
The Lancet Oncology
Oncology
Current Therapies and Emerging Targets for the Treatment of Diabetes
